Cao J - Search Results

1

Cellular Senescence and Anti-Cancer Therapy.

You J, Dong R, Ying M, He Q, Cao J, Yang B. You J, et al. Among authors: cao j. Curr Drug Targets. 2019;20(7):705-715. doi: 10.2174/1389450120666181217100833. Curr Drug Targets. 2019. PMID: 30556499 Review.

2

Involvement of immune response in anti-tumor effects of Staphylococcus aureus filtrate preparation.

Zhang B, Fang Y, Cao J, Zhang C, Ying M, He Q, Yang B. Zhang B, et al. Among authors: cao j. J Cancer Res Clin Oncol. 2008 Mar;134(3):373-9. doi: 10.1007/s00432-007-0293-y. Epub 2007 Aug 7. J Cancer Res Clin Oncol. 2008. PMID: 17680268

3

Synthesis and evaluation of novel 7-azaindazolyl-indolyl-maleimide derivatives as antitumor agents and protein kinase C inhibitors.

Ye Q, Cao J, Zhou X, Lv D, He Q, Yang B, Hu Y. Ye Q, et al. Among authors: cao j. Bioorg Med Chem. 2009 Jul 1;17(13):4763-72. doi: 10.1016/j.bmc.2009.04.043. Epub 2009 May 3. Bioorg Med Chem. 2009. PMID: 19447039

4

ROS-driven Akt dephosphorylation at Ser-473 is involved in 4-HPR-mediated apoptosis in NB4 cells.

Cao J, Xu D, Wang D, Wu R, Zhang L, Zhu H, He Q, Yang B. Cao J, et al. Free Radic Biol Med. 2009 Sep 1;47(5):536-47. doi: 10.1016/j.freeradbiomed.2009.05.024. Epub 2009 May 28. Free Radic Biol Med. 2009. PMID: 19482076

5

Efficient activation of p53 pathway in A549 cells exposed to L2, a novel compound targeting p53-MDM2 interaction.

Zhang L, Zhang J, Hu C, Cao J, Zhou X, Hu Y, He Q, Yang B. Zhang L, et al. Among authors: cao j. Anticancer Drugs. 2009 Jul;20(6):416-24. doi: 10.1097/cad.0b013e32832aa7b0. Anticancer Drugs. 2009. PMID: 19579266

6

YQ36: a novel bisindolylmaleimide analogue induces KB/VCR cell death.

Cao J, Zhang L, Ye Q, Zhou X, Lou J, Zhu D, Hu Y, He Q, Yang B. Cao J, et al. J Biomed Biotechnol. 2009;2009:535072. doi: 10.1155/2009/535072. Epub 2010 Jan 4. J Biomed Biotechnol. 2009. PMID: 20069125 Free PMC article.

7

Abrogation of Akt signaling by Isobavachalcone contributes to its anti-proliferative effects towards human cancer cells.

Jing H, Zhou X, Dong X, Cao J, Zhu H, Lou J, Hu Y, He Q, Yang B. Jing H, et al. Among authors: cao j. Cancer Lett. 2010 Aug 28;294(2):167-77. doi: 10.1016/j.canlet.2010.01.035. Epub 2010 Feb 18. Cancer Lett. 2010. PMID: 20167420

8

5k, a novel β-O-demethyl-epipodophyllotoxin analogue, inhibits the proliferation of cancer cells in vitro and in vivo via the induction of G2 arrest and apoptosis.

Xu D, Cao J, Qian S, Li L, Hu C, Weng Q, Lou J, Zhu D, Zhu H, Hu Y, He Q, Yang B. Xu D, et al. Among authors: cao j. Invest New Drugs. 2011 Oct;29(5):786-99. doi: 10.1007/s10637-010-9423-5. Epub 2010 Mar 30. Invest New Drugs. 2011. PMID: 20352292

9

Celastrol acts as a potent antimetastatic agent targeting beta1 integrin and inhibiting cell-extracellular matrix adhesion, in part via the p38 mitogen-activated protein kinase pathway.

Zhu H, Liu XW, Cai TY, Cao J, Tu CX, Lu W, He QJ, Yang B. Zhu H, et al. Among authors: cao j. J Pharmacol Exp Ther. 2010 Aug;334(2):489-99. doi: 10.1124/jpet.110.165654. Epub 2010 May 14. J Pharmacol Exp Ther. 2010. PMID: 20472666

10

Q39, a quinoxaline 1,4-Di-N-oxide derivative, inhibits hypoxia-inducible factor-1α expression and the Akt/mTOR/4E-BP1 signaling pathway in human hepatoma cells.

Weng Q, Zhang J, Cao J, Xia Q, Wang D, Hu Y, Sheng R, Wu H, Zhu D, Zhu H, He Q, Yang B. Weng Q, et al. Among authors: cao j. Invest New Drugs. 2011 Dec;29(6):1177-87. doi: 10.1007/s10637-010-9462-y. Epub 2010 Jun 5. Invest New Drugs. 2011. PMID: 20524035

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,825 results

Search Page

Filters